Compounds > 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran
Page last updated: 2024-09-03

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and bradykinin

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with bradykinin in 1 studies

Compound Research Comparison

Studies
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Trials
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Recent Studies (post-2010)
(2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)		Studies
(bradykinin)		Trials
(bradykinin)		Recent Studies (post-2010) (bradykinin)
630014,1953551,520

Protein Interaction Comparison

ProteinTaxonomy2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran (IC50)bradykinin (IC50)
B2 bradykinin receptorHomo sapiens (human)0.0018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beattie, TR; Biftu, T; Hwang, SB; Lam, MH; Shen, TY1

Other Studies

1 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and bradykinin

ArticleYear
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    The Journal of biological chemistry, 1985, Dec-15, Volume: 260, Issue:29

    Topics: Animals; Benzofurans; Benzopyrans; Blood Platelets; Bradykinin; Capillary Permeability; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Furans; Histamine; Humans; Lignans; Magnesium; Mathematics; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sodium; Thiazoles

1985